Evidence map›Paper›PMID 30353742›Full record

ArticleAmerican journal of physiology. Renal physiology2019

Bladder decompensation and reduction in nerve density in a rat model of chronic bladder outlet obstruction are attenuated with the NLRP3 inhibitor glyburide.

Francis M Hughes, Stephanie J Sexton, Patrick D Ledig, Chloe E Yun, Huixia Jin, J Todd Purves

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Francis M HughesDepartment of Surgery, Division of Urology, Duke University Medical Center , Durham, North Carolina.ORCID 0000-0003-3776-3653
Stephanie J SextonDepartment of Surgery, Division of Urology, Duke University Medical Center , Durham, North Carolina.
Patrick D LedigDepartment of Surgery, Division of Urology, Duke University Medical Center , Durham, North Carolina.
Chloe E YunDepartment of Surgery, Division of Urology, Duke University Medical Center , Durham, North Carolina.
Huixia JinDepartment of Surgery, Division of Urology, Duke University Medical Center , Durham, North Carolina.
J Todd PurvesDepartment of Surgery, Division of Urology, Duke University Medical Center , Durham, North Carolina.
Duke Medical Center · US

Funding

Inflammasomes Mediate Inflammation in Bladder Outlet ObstructionR01DK103534 · NIDDK · DUKE UNIVERSITY · PI PURVES, J. TODD · 2015 to 2018
$1.6M
NIDDK NIH HHS R01 DK103534
6 · The paper itself

Abstract

Bladder outlet obstruction (BOO) leads to progressive voiding dysfunction. Acutely, obstruction triggers inflammation that drives bladder dysfunction. Over time, inflammation leads to decreased bladder nerve density and increased fibrosis, responsible for eventual decompensation and irreversibility. We have previously shown that BOO triggers inflammation, reduced bladder nerve density and increased fibrosis via activation of the NLRP3 inflammasome in an acutely obstructed (12-day) rat model. However, as BOO progresses, the bladder may become decompensated with an increase in postvoid residual volume and decreased voiding efficiency. Currently, we have examined rat bladder function and nerve densities after chronic BOO to determine whether NLRP3 plays a role in the decompensation at this stage. Four groups were examined: control, sham-operated, BOO, or BOO+gly (glyburide; an NLRP3 inhibitor). After 42 days, bladder weight, inflammation (Evans blue), urodynamics, and nerve density were measured. BOO greatly enhanced bladder weights and inflammation, while inflammation was prevented by glyburide. Voiding pressures were increased, and flow rates decreased in BOO and BOO+gly groups, demonstrating physical obstruction. No difference in frequency or voided volume was detected. However, postvoid residual volumes were greatly increased in BOO rats while BOO+gly rats were not different than controls. Moreover, there was a dramatic decrease in voiding efficiency in the chronic BOO rats, which was prevented with glyburide treatment. Finally, a reduction in nerve density was apparent with BOO and attenuated with glyburide. Together the results suggest a critical role for NLRP3 in mediating bladder decompensation and nerve density during chronic BOO.

Indexed as

AnimalsAnti-Inflammatory AgentsAutonomic Nervous SystemChronic DiseaseCystitisDisease Models, AnimalFemaleGlyburideNLR Family, Pyrin Domain-Containing 3 ProteinRats, Sprague-DawleySignal TransductionUrinary BladderUrinary Bladder Neck ObstructionUrodynamicsAnti-Inflammatory AgentsGlyburideNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratbladdercystitisinnervationoutlet obstructionurodynamics

Identifiers

PMID30353742
PMCPMC6383202
OpenAlexW2898364093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.